Neil Josephson - 07 Jan 2022 Form 4 Insider Report for Zymeworks Inc.

Role
Chief Medical Officer
Signature
s/ Daniel Dex, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
07 Jan 2022
Net transactions value
+$71,386
Form type
4
Filing time
11 Jan 2022, 20:47:16 UTC
Previous filing
12 Nov 2021
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZYME Common Shares Purchase $19,978 +1,400 +66% $14.27* 3,519 07 Jan 2022 Direct
transaction ZYME Common Shares Purchase $51,408 +3,600 +102% $14.28* 7,119 07 Jan 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.